Project Grant R01HL186358
Award Date 7/1/26
Completion Date 4/30/30
Dollars Obligated $712K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92697, USA
Similar Awards
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of California, Irvine a $621,546 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) on July 20, 2025, for a four-year research initiative extending through June 30, 2029. This grant supports development of novel single-molecule enzymology techniques using printed carbon nanotube field effect transistors (SWNT FETs) to study protein kinase A (PKA-C) catalytic...
- Federal Project Grant Award Summary The University of California, San Diego received a $1,519,594 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025 through May 31, 2029. The award supports fundamental research to advance understanding of biological mechanisms in the infarct borderzone—the critical region between dead and healthy heart tissue following myocardial infarction. This...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $498,000 to the University of California, Irvine under the Cardiovascular Diseases Research program (CFDA 93.837) on July 21, 2025, with a completion date of June 30, 2028. This project grant funds research to identify novel epigenetic regulators of lymphocyte development, specifically focusing on T cell development and function. The research addresses a critical gap in understanding epigenetic...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the Regents of the University of California, San Francisco a $556,295 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) effective August 1, 2025, with completion scheduled for May 31, 2030. This award supports research to advance understanding of cardiac pacemaking physiology and sinus node dysfunction (SND) through investigation of specialized pacemaker cell subpopulations. The...
- Federal Project Grant Award Summary The University of California, San Diego received a $609,574 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 1, 2026, with a completion date of March 31, 2030. The grant funds basic research investigating the cellular and molecular mechanisms that regulate cardiac chamber morphology, specifically how cardiomyocytes acquire distinct shapes and organizational...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $231,552 Project Grant to the University of California, San Diego on September 16, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837). This research project, titled "Tissue Elasticity and Viscosity Modulates Macrophage-Fibroblast Signaling in Cardiac Fibrosis," focuses on investigating the mechanisms underlying cardiac fibrosis through the study of interactions between...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant totaling $811,885 to the J. David Gladstone Institutes under the Cardiovascular Diseases Research program (CFDA 93.837) on September 12, 2025. The award funds research to elucidate epigenomic mechanisms of cardiac fibrosis and heart failure pathogenesis, with a completion date of May 31, 2029. The research leverages novel genetic mouse models, advanced transcriptional and epigenomic...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of California, Irvine a $1.207 million Project Grant (CFDA 93.837 – Cardiovascular Diseases Research) on August 15, 2025, to develop an integrated optical coherence tomography/ultrasound/photoacoustic tomography (OCT/US/PAT) system for intravascular imaging of atherosclerotic plaques. The research addresses coronary artery disease, which affects over 18 million adults and causes...
- Grant Award Summary The University of California, San Diego received a $799,256 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 5, 2026, with completion targeted for March 31, 2031. The award funds basic research investigating cardiac protection through neuromodulation following myocardial infarction. The research employs an integrated cardiac-neuro-immune approach examining three key...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,113,961 Project Grant to The Regents of the University of California, San Francisco on August 10, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to support research investigating how centrioles direct mammalian development. The research focuses on understanding the molecular and cell biological mechanisms through which centriole defects contribute to congenital heart disease,...